Clinical trial
A Study of the Effects of Pegvisomant on Growth Hormone Excess in…
NCT00017927 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Completed
Key facts
| NCT number | NCT00017927 |
|---|---|
| Title | A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome |
| Official title | A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | McCune Albright Syndrome, Polyostotic Fibrous Dysplasia |
| Intervention type | Drug |
| Interventions | Pegvisomant |
| Enrollment | 10 |
| Start date | Jun 1, 2001 |
| Completion | Jun 1, 2005 |
| First posted | Jun 21, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: